
Prostate Cancer Survivorship
Background Between 1999 and 2009 in the UK, 82,429 men aged 50 to 69 received a prostate-specific antigen (PSA) test. Localized prostate cancer was diagnosed in 2664 men. Of these men, 1643 were enrolled in a trial to evaluate the effectiveness of treatments, with 545 randomly assigned to receive active monitoring, 553 to undergo prostatectomy […]